KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Change in Receivables (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Change in Receivables for 16 consecutive years, with -$1.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Receivables fell 257.18% to -$1.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$264000.0, a 109.11% decrease, with the full-year FY2025 number at -$264000.0, down 109.11% from a year prior.
  • Change in Receivables was -$1.9 million for Q4 2025 at Biolife Solutions, down from $782000.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $7.0 million in Q2 2022 to a low of -$5.9 million in Q4 2023.
  • A 5-year average of $408450.0 and a median of $837500.0 in 2025 define the central range for Change in Receivables.
  • Peak YoY movement for Change in Receivables: tumbled 549.73% in 2023, then skyrocketed 475.96% in 2025.
  • Biolife Solutions' Change in Receivables stood at $3.0 million in 2021, then tumbled by 56.05% to $1.3 million in 2022, then crashed by 549.73% to -$5.9 million in 2023, then surged by 120.85% to $1.2 million in 2024, then tumbled by 257.18% to -$1.9 million in 2025.
  • Per Business Quant, the three most recent readings for BLFS's Change in Receivables are -$1.9 million (Q4 2025), $782000.0 (Q3 2025), and $893000.0 (Q2 2025).